NCT04366024View on ClinicalTrials.gov

A Novel Nomogram to Predict Severity of COVID-19

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

December 31, 2021

Conditions
COVID-19 DiseaseNomogram Model
Interventions
OTHER

other

clinical diagnosis

Trial Locations (1)

400000

Xinqiao Hospital of Chongqing, Chongqing

All Listed Sponsors
lead

Xinqiao Hospital of Chongqing

OTHER

NCT04366024 - A Novel Nomogram to Predict Severity of COVID-19 | Biotech Hunter | Biotech Hunter